Abstract
In recent years, high plasma homocysteine (HHcy) as an independent risk factor for coronary atherosclerotic heart disease (CHD) has been widely received clinical attention. Some detection methods and clinical research for patients with CHD are constantly developing. Enzymatic cycling assay, the most commonly used method at present, represents important application value in the aspects of disease occurrence, severity prediction and therapeutic monitoring for CHD.(Chin J Lab Med, 2016, 39: 726-728) Key words: Coronary disease; Homocysteine; Severity of illness index
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
